Genetic Analysis AS reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 3.65 million compared to NOK 2.98 million a year ago. Revenue was NOK 5.7 million compared to NOK 5.48 million a year ago. Net loss was NOK 5.49 million compared to NOK 6.06 million a year ago. Basic loss per share from continuing operations was NOK 0.22 compared to NOK 0.24 a year ago. Diluted loss per share from continuing operations was NOK 0.22 compared to NOK 0.24 a year ago.
For the six months, sales was NOK 7.77 million compared to NOK 5.48 million a year ago. Revenue was NOK 12.07 million compared to NOK 10.32 million a year ago. Net loss was NOK 12.83 million compared to NOK 13.79 million a year ago. Basic loss per share from continuing operations was NOK 0.51 compared to NOK 0.55 a year ago. Diluted loss per share from continuing operations was NOK 0.51 compared to NOK 0.55 a year ago.